Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

HPV/Oropharynx/Re-treatment/Personalized Radiotherapy/Value-based Care
Oral Cavity/Melanoma/Non-melanoma Skin
Larynx/Thyroid
Salivary Gland/Paranasal Sinus/Parapharyngeal Space Tumors/QOL/Immunotherapy
Event

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Is Dose De-escalated Radiation Ready for Prime Time in Favorable HPV-associated Oropharynx Cancer?

By Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update FEATURING John F. Greskovich

0 views

March 17, 2020

Comments 0

HPV/Oropharynx/Re-treatment/Personalized Radiotherapy/Value-based Care